Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,975,643
-$641,300 QoQ
Shares Held
82,045
-12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#972
of 2,820 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. PFE ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
This page
|
82,045 | $1,975,643 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,975,643 | 82,045 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,616,943 | 93,196 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,989,220 | 120,049 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,347,027 | 131,359 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,823,717 | 116,490 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,006,615 | 118,651 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,307,256 | 124,661 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,140,532 | 143,073 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,304,918 | 153,857 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $5,604,694 | 201,971 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,271,453 | 287,303 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,711,753 | 322,935 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,249,996 | 388,495 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $17,078,797 | 418,598 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $32,017,518 | 624,854 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $27,681,393 | 632,573 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $32,362,417 | 617,250 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $31,615,162 | 610,685 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $31,002,607 | 525,023 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $21,708,823 | 504,739 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $19,536,809 | 539,244 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $28,071,894 | 762,616 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $30,832,409 | 840,121 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $25,070,134 | 766,670 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $22,767,510 | 697,535 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||